Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse

Journal of Clinical Oncology

Volumn 23, Issue 15, 2005, Pages 3447-3454

  Aversa, Franco ^a   Terenzi, Adelmo ^a   Tabilio, Antonio ^a   Falzetti, Franca ^a   Carotti, Alessandra ^a   Ballanti, Stelvio ^a   Felicini, Rita ^a   Falcinelli, Flavio ^a   Velardi, Andrea ^a   Ruggeri, Loredana ^a   Aloisi, Teresa ^a   Saab, Jean Pierre ^a   Santucci, Antonella ^a   Perruccio, Katia ^a   Martelli, Maria Paola ^a   Mecucci, Cristina ^a   Reisner, Yair ^a   Martelli, Massimo F ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; FLUDARABINE; FOSCARNET; GANCICLOVIR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THIOTEPA; THYMOCYTE ANTIBODY;

ACUTE LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER RELAPSE; CANCER SURVIVAL; CD34 SELECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT VERSUS HOST REACTION; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MISMATCH REPAIR; PERIPHERAL BLOOD STEM CELL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; WHOLE BODY RADIATION; ACUTE GRANULOCYTIC LEUKEMIA; CHILD; COMPARATIVE STUDY; CONFIDENCE INTERVAL; FOLLOW UP; GRAFT SURVIVAL; HISTOCOMPATIBILITY TEST; HOSPITALIZATION; IMMUNOSUPPRESSIVE TREATMENT; LIVING DONOR; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; RECURRENT DISEASE; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; CONFIDENCE INTERVALS; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HAPLOTYPES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; LIVING DONORS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 20644470338     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.09.117     Document Type: Article

References (33)

1. Burnett AK, Wheatley K, Goldstone AH, et al: The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: Results of the UK MRC AML 10 trial. Br J Haematol 118:385-400, 2002
2. Hoelzer D, Gokbuget N, Ottmann O, et al: Acute lymphoblastic leukemia. Hematology (Am Soc Hematol Educ Program) 162-192, 2002
3. Schipper RF, D'Amaro J, Bakker JT, et al: HLA gene haplotype frequencies in bone marrow donors worldwide registries. Hum Immunol 52:54-71, 1997
4. Gluckman E, Rocha V, Chevret S: Results of unrelated umbilical cord blood hematopoietic stem cell transplantation. Rev Clin Exp Hematol 5:87-99, 2001
5. Sanz MA, Sanz GF: Unrelated donor umbelical cord blood transplantation in adults. Leukemia 16:1984-1991, 2002
6. Anasetti C, Beatty PG, Storb R, et al: Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Hum Immunol 29:79-91, 1990
7. Kernan NA, Flomemberg N, Dupont B, et al: Graft rejection in recipients of T cell depleted HLA-nonidentical marrow transplants for leukemia: Identification of host derived anti-donor allocytotoxic T lymphocytes. Transplantation 43: 482-487, 1987
8. Aversa F, Tabilio A, Terenzi A, et al: Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 84:3948-3955, 1994
9. Aversa F, Tabilio A, Velardi A, et al: Treatment of high risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 339:1186-1193, 1998
10. Bachar-Lusting E, Rachamim N, Li HW, et al: Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice. Nat Med 1:1268-1273, 1995
11. Tabilio A, Falzetti F, Giannoni C, et al: Stem cell mobilization in normal donors. J Hematother 6:227-234, 1997
12. Ruggeri L, Capanni M, Urbani E, et al: Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295:2097-2100, 2002
13. Przepiorka D, Weisdorf D, Martin P, et al: Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 15:825-828:1995, 1994
14. Gray RJ: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Statistics 16:1141-1154, 1988
15. Rachamin N, Gan J, Segall R, et al: Tolerance induction by "megadose" hematopoietic transplants: Donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture. Transplantation 65: 1386-1393, 1998
16. Reisner Y, Gur H, Reich-Zeliger S, et al: Hematopoietic stem cell transplantation across major genetic barriers: Tolerance induction by megadose CD34 cells and other veto cells. Ann N Y Acad Sci 996:72-79, 2003
17. Gur H, Krauthgamer R, Berrebi A, et al: Tolerance induction by megadose hematopoietic progenitor cells: Expansion of veto cells by short-term culture of purified human CD34(+) cells. Blood 99:4174-4181, 2002
18. + progenitor cells from HLA-mismatched parental donors in children. Bone Marrow Transplant 27:777-783, 2001
19. Gluckman E, Rocha V, Arcese W, et al: Factors associated with outcomes of unrelated cord blood transplant: Guidelines for donor choice. Exp Hematol 32:397-407, 2004
20. Rocha V, Labopin M, Sanz G, et al: Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 351:2276-2285, 2004
21. Weisdorf D, Bishop M, Dharan B, et al: Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: Comparative toxicity and outcomes. Biol Blood Marrow Transplant 8:213-220, 2002
22. Petersdorf EW: Hematopoietic cell transplantation from unrelated donors, in Blume KG, Forman SJ, Appelbaum FR (eds): Thomas' Hematopoietic Cell Transplantation Blackwell Publishers. Maiden, MA, Blackwell Publishers, 2004, pp 1132-1149
23. Sierra J, Storer B, Hansen JA, et al: Unrelated donor marrow transplantation for acute myeloid leukemia: An update of the Seattle experience. Bone Marrow Transplant 26:397-404, 2000
24. Heitger A, Greinix H, Mannhalter C, et al: Requirement of residual thymus to restore normal T-cell subsets after human allogeneic bone marrow transplantation. Transplantation 69: 2366-2373, 2000
25. Laughlin MJ, Barker J, Bambach B, et al: Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 344:1815-1822, 2001
26. Volpi I, Perruccio K, Tosti A, et al: Post-grafting granulocyte colony-stimulating factor administration impairs functional immune recovery in recipients of HLA haplotype-mismatched hematopoietic transplants. Blood 97:2514-2521, 2001
27. Andre-Schmutz I, Le Deist F, Hacein-Bey S, et al: Donor T lymphocyte infusion following ex vivo depletion of donor anti-host reactivity by a specific anti-interleukin-2 receptor P55 chain immunotoxin. Transplant Proc 34:2927-2928, 2002
28. + T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants. Blood 103:3565-3572, 2004
29. Aversa F, Terenzi A, Carotti A, et al: Improved outcome with T-cell-depleted bone marrow transplantation for acute leukemia. J Clin Oncol 17:1545-1550, 1999
30. Papadopoulos E, Carabasi MH, Castro-Malaspina H, et al: T-cell-depleted allogeneic bone marrow transplantation as post-remission therapy for acute myelogenous leukemia: Freedom from relapse in the absence of graft versus host disease. Blood 91:1083-1090, 1998
31. Velardi A, Ruggeri L, Capanni M, et al: Impact of NK Cell Alloreactivity on Mismatched Hematopoietic Transplantation: An Update on Donor Selection Criteria and on Transplantation Outcomes. Blood 102, 2003 (abstr 527)
32. Laughlin MJ, Eapen M, Rubinstein P, et al: Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 351:2265-2275, 2004
33. Kollman C, Weis T, Switzer GE, et al: Non-HLA barriers to unrelated donor stem cell transplantation. Bone Marrow Transplant 27: 581-587, 2001